Why can the body’s response change over time?

Rapid desensitisation and slower tolerance

Desensitisation means a reduced response during continuous or repeated exposure. Tachyphylaxis commonly describes a particularly rapid form. Tolerance usually describes a more gradual loss of response over days or weeks. These labels are conventions, not universal time cut-offs.

Several changes may contribute. Receptors can acquire phosphate tags in a process called phosphorylation, or become fewer at the cell surface. Later signalling can change, or a mediator can become depleted. The body can also respond in a way that counteracts the effect.21

Exposure and response are different measurements

A lower effect can reflect lower concentration rather than a less responsive target. Absorption, clearance, kidney or liver function, food, co-medications and adherence can change exposure. If the drug reaches similar concentrations over time but the response is smaller, adaptation in how the body responds to it becomes more plausible. This is called pharmacodynamic adaptation. Both processes can occur together, so a before-and-after experience cannot identify the cause on its own.31

Tolerance and resistance describe different questions

Tolerance usually describes a reduced response to a drug after repeated exposure. In antimicrobial and cancer treatment, resistance commonly refers to organisms or tumour cells that no longer respond as expected; the term is also used in other clinical contexts, so its meaning depends on the setting. Resistance in cancer cells or microorganisms can be present before treatment or arise during it. A medicine can also appear less effective because the illness progressed, the target changed or the outcome was measured later.28

Dependence, withdrawal and addiction ask different questions

Physical dependence is an adaptive state in which reducing or stopping regular exposure can produce withdrawal. It can occur with medically appropriate use and does not by itself establish addiction. Addiction involves compulsive seeking or use despite harmful consequences and impaired control. Tolerance or withdrawal may accompany addiction, but neither is sufficient to diagnose it. Withdrawal is medicine-specific and can reflect rebound when counter-regulatory changes are exposed after stopping.562

A clinical example: nitrate tolerance

A historical U.S. label for a nitroglycerin patch used to prevent angina summarizes controlled studies that measured exercise tolerance during continuous nitrate exposure. In most of those studies, the measured anti-anginal effect was no longer distinguishable from placebo by 24 hours or less, although some patch trials reported maintained effects. The same label describes one controlled study in which exercise tolerance at the end of a drug-free interval was lower than with placebo, a possible rebound finding. This example shows why a time point and comparator matter, and why tolerance and rebound deserve separate attention. It does not imply that every medicine behaves this way or provide a treatment schedule.7

A worked evidence question

If a blood-pressure medicine seems to have a smaller effect after several weeks, possible explanations include changed adherence, faster clearance after a new medicine, physiological counter-regulation, disease progression or different measurement conditions. A careful study defines the outcome and time points, tracks exposure and co-medications, and includes a relevant comparison. One higher reading cannot distinguish these possibilities.43

Changes can be local or system-wide

A response may fade in one tissue while another effect remains. Receptor internalisation, altered coupling and downstream feedback can be tissue-specific, and a medicine can have several targets with different adaptation rates. A cell-culture assay may therefore show desensitisation of one signal without establishing tolerance to the medicine’s patient-important effect. A clinical result needs the relevant population, exposure, outcome and time point.214

Rebound is not proof of addiction

When a drug has been suppressing a physiological process, counter-regulation can become visible after exposure falls. The resulting rebound may resemble the original condition or produce a new symptom, but it does not by itself show compulsive use or impaired control. Conversely, the absence of obvious withdrawal does not prove that a medicine has no adverse effects or that a person’s use is uncomplicated. Dependence and addiction require different evidence.256

What a good study records

To investigate a changing response, researchers can prespecify repeated outcome measurements, document dose timing and co-medications, measure exposure when relevant, and retain a comparison group. They should report withdrawals, missing observations, protocol changes and whether analyses were planned before looking at the data. A single post-treatment measurement can describe a pattern, but it cannot establish the mechanism that produced it.41

Why before-and-after changes need a comparison

A response that becomes smaller after repeated exposure is a pattern to investigate, not a diagnosis of tolerance. Symptoms and measurements fluctuate, people may change how they take a medicine, and regression toward a usual value can make an extreme first measurement look as if it improved or worsened on its own. A concurrent comparison group, prespecified time points and exposure measurements help separate adaptation from those alternatives. Even then, the result applies to the studied outcome, product and population; it does not automatically explain every effect of the medicine.431

What to ask when a response changes

What changed: concentration, molecular response, symptom, laboratory value or patient-important outcome? Over what period, and measured how? Could exposure, interactions, organ function or disease progression explain it? Is the proposed mechanism pharmacokinetic, pharmacodynamic, behavioural or mixed? Does the source distinguish tolerance, desensitisation, dependence, withdrawal, addiction and resistance? This page is educational and is not a reason to alter or stop an individual treatment.45